Genomic characterisation of a novel KPC-98-producing clinical Klebsiella pneumoniae strain conferring resistance to ceftazidime/avibactam

Int J Antimicrob Agents. 2023 Dec;62(6):107013. doi: 10.1016/j.ijantimicag.2023.107013. Epub 2023 Oct 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Azabicyclo Compounds / pharmacology
  • Bacterial Proteins / genetics
  • Ceftazidime* / pharmacology
  • Drug Combinations
  • Genomics
  • Humans
  • Klebsiella Infections* / drug therapy
  • Klebsiella pneumoniae / genetics
  • Microbial Sensitivity Tests
  • beta-Lactamases / genetics

Substances

  • Ceftazidime
  • avibactam
  • Anti-Bacterial Agents
  • Azabicyclo Compounds
  • Drug Combinations
  • beta-Lactamases
  • Bacterial Proteins